By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


Key Statistics

Ownership: Public

Web Site: Bristol-Myers Squibb
Symbol: BMY



PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech, Inc.  - Cancer

Gilead (Seattle, WA) 

Company News
FDA Green Lights Bristol-Myers Squibb (BMY)'s Drug Combo for Metastatic Melanoma 10/1/2015 6:53:08 AM
Bristol-Myers Squibb (BMY) Announces FDA Regulatory Filing Update For The Opdivo+Yervoy Regimen In Patients With Previously Untreated Advanced Melanoma 9/28/2015 2:05:55 PM
Bristol-Myers Squibb (BMY) Release: Opdivo (nivolumab) Demonstrates Superior Overall Survival In A Phase 3 Trial Compared To Standard Of Care In Patients With Previously Treated Advanced Renal Cell Carcinoma 9/28/2015 2:02:35 PM
Bristol-Myers Squibb (BMY) Release: Opdivo (nivolumab) Demonstrates Long Term Survival Benefit In Patients With Previously Treated Non-Squamous Non-Small Cell Lung Cancer In Checkmate -057 9/28/2015 1:32:15 PM
Bristol-Myers Squibb (BMY) Launches Working Together For Patients, A Program Highlighting The Company‚Äôs Commitment To Patients 9/28/2015 12:33:34 PM
Bristol-Myers Squibb (BMY) And H. Lee Moffitt Cancer Center & Research Institute Enter Into A Collaboration Agreement As Part Of U.S. Immuno-Oncology Rare Population Malignancy Program 9/25/2015 8:39:22 AM
Albireo Appoints Ron Cooper, Former President Of Europe At Bristol-Myers Squibb (BMY), As CEO 9/23/2015 7:23:56 AM
Bristol-Myers Squibb (BMY) Announces Dividend 9/18/2015 9:34:30 AM
Bristol-Myers Squibb (BMY) Grabs Breakthrough Tag for Opdivo 9/16/2015 8:51:07 AM
Bristol-Myers Squibb (BMY) To Take Part In Morgan Stanley Global Health Care Conference 9/10/2015 11:21:13 AM